Cadrenal Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Percent
Cadrenal Therapeutics, Inc. (CVKD) reported Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Percent of -0.20% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign · last filed 2026-03-31
- Cadrenal Therapeutics, Inc. effective income tax rate reconciliation, tax settlement, foreign, percent for fiscal 2025 was -0.20%.
- Cadrenal Therapeutics, Inc. effective income tax rate reconciliation, tax settlement, foreign, percent for fiscal 2024 was -0.10%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Percent 12 month |
|---|---|
| 2025-12-31 | -0.20% 10-K · filed 2026-03-31 |
| 2024-12-31 | -0.10% 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B |